Cirque du Soleil Reopens Vegas Shows in Sign of Vaccine Optimism

(Bloomberg) —

Cirque du Soleil Entertainment Group, which emerged from court protection with new owners last year, will reopen four shows in the coming months, including two in Las Vegas this summer, in a sign of optimism as vaccination progresses.

The Montreal-based company, which was forced to close all its venues due to Covid-19, will first launch at Vegas hotels with “Mystere” starting on June 28, followed by “O” on July 1, the company said in a statement Wednesday. Touring will resume with a show in Punta Cana, Dominican Republic, in November. London’s Royal Albert Hall will host a fourth one in January 2022.

Two shows, in China and Mexico, had already resumed. But the return to Vegas is key for the company.

“This is the moment we have all been waiting for” after an almost 400-day hiatus, Chief Executive Officer Daniel Lamarre said in a statement.

In a November interview, Lamarre said vaccine distribution on a large scale would be required for people to feel comfortable returning to Cirque’s live venues. The U.S. has been making strides in its vaccination campaign, with 40% of its population having received at least one dose, according to the Bloomberg Vaccine Tracker.

He’d predicted operations would start first in Vegas, where it has signed extensions for five of its shows. Blue Man Group, which Cirque bought in 2017, will also relaunch there on June 24, the company said.

Follow us on social media for the latest updates in B2B!

Image

Latest

physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card
December 2, 2025

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…

Read More
Laying Out the Landscape in Today’s Patient Monitoring
Laying Out the Landscape in Today’s Patient Monitoring
December 2, 2025

More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today’s patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel’s Kaeli Tully, Solutions Engineer…

Read More
Culture
People-Centric HR in Practice: How Jen Schomer Turns Organizational Chaos into a Culture of Trust and Performance
December 2, 2025

In today’s whiplash workplace—where startups scale fast, funding dries up faster, and employee expectations keep evolving—HR isn’t a back-office function anymore. The rise of fractional leadership, remote teams, and constant regulatory change has forced companies to rethink how they support people while still hitting business goals. Leaders are realizing that “culture issues” often trace…

Read More